Delivery Order SPE2DR25D2018-SPE2DR26FZ1A3
Award Date 1/28/26
Potential Completion Date 1/29/26
Potential Value $15K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $28,435.61 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 21, 2026, for the supply of Zepbound 15 mg/0.5 ml pens. The order, with an ultimate completion date of January 22, 2026, will be performed at the awardee's location in Conshohocken, Pennsylvania. This delivery order was awarded competitively with no set-aside designation and represents a single task order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $30,754.05 delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 27, 2026, for the supply of Zepbound 7.5 mg/0.5 mL pens, with a completion date of January 28, 2026. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates...
- The Defense Logistics Agency awarded a $1,607.32 firm fixed-price delivery order to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) on January 15, 2026, for the supply of Zepbound 5 mg/0.5 mL pens. The contract has an ultimate completion date of January 16, 2026, and is non-competitive with no set-aside designation. Performance will occur at the awardee's corporate office in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. (formerly known as...
- The Defense Logistics Agency awarded a $3,094.84 delivery order to AmerisourceBergen Drug Corp (a subsidiary of parent company Cencora, Inc.) on January 23, 2026, for the supply of Zepbound 15 mg/0.5 mL pens. This firm fixed-price delivery order is scheduled for completion by January 26, 2026, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award was made on a competitive, non-set-aside basis and represents a task order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $9,850.74 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens on January 14, 2026, with an ultimate completion date of January 15, 2026. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc. (which...
- The Defense Logistics Agency awarded a $31,315.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 14, 2026, for the supply of Zepbound 7.5 mg/0.5 ml pen injections. This non-set-aside award was completed on January 15, 2026, with performance at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $20,902.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Zepbound 5 mg/0.5 mL pens. This contract, which carries an ultimate completion date of July 28, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order was competitively awarded without set-aside...
- The Defense Logistics Agency awarded a $8,337.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 20, 2026, for the supply of Zepbound 5 mg/0.5 mL pens with a completion date of January 21, 2026. The award was issued on a non-set-aside, competitive basis and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,149.76 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 15, 2026, for the supply of Zepbound 7.5 mg/0.5 mL pen injections. The contract is a firm fixed-price delivery order with an ultimate completion date of January 16, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was made on a non-set-aside, fully competitive basis, consistent with AmerisourceBergen's standard...
- The Defense Logistics Agency awarded a $14,518.84 delivery order to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 ml pens on July 15, 2025, with completion scheduled for July 16, 2025. This competitive award carries firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in...